First-in-man clinical trial of the oral pan-AKT inhibitor MK-206 in patients with advanced solid tumors

Timothy A. Yap, Li Yan, Amita Patnaik, Ivy Fearen, David Olmos, Kyriakos Papadopoulos, Richard D. Baird, Liliana Delgado, Adekemi Taylor, Lisa Lupinacci, Ruth Riisnaes, Lorna L. Pope, Simon P. Heaton, George Thomas, Michelle D. Garrett, Daniel M. Sullivan, Johann S. De Bono, Anthony W. Tolcher

Research output: Contribution to journalArticlepeer-review

451 Scopus citations

Fingerprint

Dive into the research topics of 'First-in-man clinical trial of the oral pan-AKT inhibitor MK-206 in patients with advanced solid tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences